Hikma Pharmaceuticals PLC

HKMPY·OTC Markets OTCPK·Healthcare
Compare
47.75+1.25 (+2.69%)today
At close: Nov 4, 11:48 AM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close46.50
Open47.75
Day range—
52-week range31.8047.75
Off day high0.00%
Off 52-week high0.00%
Volume100
Avg. volume (3M)260
Market cap4.94B
EPS (TTM)3.52
Forward P/E—
P/E ratio (TTM)13.57
Dividend yield3.65% (1.72)
Beta (5Y)0.65
Shares outstanding103.48M
Short interest—
Earnings dateAug 7, 2025
Analyst target—
Profit margin11.32%

Against its peers

Compare in full ›
HKMPY HIKAL.NS HYPE3.SA 300584.SZ 034940.KQ KPL.BO
Market cap 4.94B 27.24B 15.26B 3.96B 9.98B 38.28B
P/E (TTM) 13.6 — 8.3 55.0 — 47.2
Forward P/E — 24.5 7.1 31.1 — —
Price/book 2.0 2.3 1.0 3.6 — 11.5
Dividend yield 3.65% 0.27% 4.86% 0.31% — —
1-year change +0.19% −10.74% −15.93% −44.94% −69.57% +317.61%
Today +2.69% −0.78% +2.90% +3.06% 0.00% −1.47%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All HKMPY news ›
Defense World··2 outletsPositive

Hikma Pharmaceuticals PLC (LON:HIK) Stock Has Consensus Price Target of GBX 2,085.83

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance